VC firm

OrbiMed

20 investors · 20 verified

Here are all investors at OrbiMed.

Investor preview

emails unlock with a plan

Investors on this list. Email addresses unlock with a plan.
namefirmemaillocationverified
Jonathan SilversteinPartnerOrbiMedUnited States1w ago
David BonitaGeneral PartnerOrbiMedUnited States1w ago
Geoffrey HsuGeneral PartnerOrbiMedUnited States3w ago
Dimitri KraincVenture PartnerOrbiMedUnited States3w ago
Jim SullivanVenture PartnerOrbiMedUnited States3w ago
Jessica ZhangSenior AssociateOrbiMedUnited States3w ago
Jonathan LeeAnalystOrbiMedUnited States3w ago
Chau KhuongPartnerOrbiMedUnited States3w ago
Charles SteinmanAnalystOrbiMedUnited States3w ago
Brendan WeberVice PresidentOrbiMedUnited States3w ago
Rishi GuptaPartnerOrbiMedUnited States3w ago
Jonathan MandelbaumSenior AssociateOrbiMedUnited States3w ago
Anat NursellaVenture PartnerOrbiMedIsrael3w ago
Mark JelleyManaging DirectorOrbiMedUnited States4w ago
Matthew RizzoPartnerOrbiMedUnited States4w ago
Peter ThompsonPartnerOrbiMedUnited States4w ago
Kevin KochVenture PartnerOrbiMedUnited States4w ago
Klaus VeitingerVenture PartnerOrbiMedUnited States4w ago
Iain DukesVenture PartnerOrbiMedUnited States4w ago
Diyong XuPrincipalOrbiMedUnited States4w ago

Browse all VCs

Recent investments at OrbiMed

  • Windward BioSeries B · $170M · 2026
  • Nucleus RadioPharmaPrivate Equity · $50M · 2026
  • Terremoto BiosciencesSeries C · $110M · 2026
  • Congruence TherapeuticsSeries Unknown · $40M · 2026
  • ProLynxSeries A · $70M · 2025
  • Aspen NeuroscienceSeries C · $120M · 2025
  • Airstrip TechnologiesDebt Financing · $50M · 2025
  • Sparrow PharmaceuticalsSeries B · $95M · 2025
  • Mondego BioSeries A · 2025
  • Epigenic TherapeuticsSeries B · $60M · 2025
  • CHARM TherapeuticsSeries B · $80M · 2025
  • vVardisSeries Unknown · $50M · 2025

What founders say

4.1Based on 11 reviews